Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Banyu identifies potent, selective muscarinic M3 antagonist series

Sep. 30, 1999

Anilines from Yamanouchi exert selective inhibition of CRACC

Sep. 27, 1999

Dual PDE4/TNF-alpha inhibitors synthesized and tested at Suntory

Sep. 24, 1999

Intranasal and i.p. administration of anti-IL-5 MAb equieffective in asthmatic mice

Sep. 24, 1999

European researchers describe novel mechanism of action for MPB-07 and MPB-27

Sep. 23, 1999

Phase II study evaluating oral levalbuterol now under way in Canada

Sep. 23, 1999

Specific inhibitors of eosinophil function from Kaken useful for asthma

Sep. 22, 1999

Chinese study shows new Cl- transport inhibitor equieffective to corticosteroids in asthma

Sep. 21, 1999

New target, new treatment for allergies and asthma discovered at Hughes Institute

Sep. 21, 1999

FDA okays new pediatric formulation of zafirlukast

Sep. 21, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...